Imara reports Phase 2a clinical trial results of IMR-687 in adult patients with sickle cell disease
(2) DJ Imara reports Phase 2a clinical trial results of IMR-687 in adult patients with sickle cell disease Arix Bioscience PLC (ARIX) Imara reports Phase 2a clinical trial results of IMR-687 in adult patients with sickle cell disease 06-Jan-2021 / 14:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Arix Bioscience plc Imara reports Phase 2a clinical trial results of IMR-687 in adult patients with sickle cell disease LONDON, 06 January 2021: Arix Bioscience plc ("Arix", ...
Source: finanznachrichten.de